Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

A case report on cefoperazone induced cardiogenic shock - kounis syndrome

Breadcrumb

  • Home
  • A case report on cefoperazone induced cardiogenic shock - kounis syndrome

C.N. Harshitha 1, * Bharat A. Vaswani 2 and Yerravalli Narasimha Rao 3

1 Senior Clinical Pharmacologist, Manager- Clinical Audit Department, Yashoda Hospitals, Behind Hari - Hara Kala Bhavan, S. P Road, Secunderabad, Telangana, India - 500003
2 Senior Consultant Haematologist and Medical Oncologist, Department of Oncology, Yashoda Hospitals, Behind Hari - Hara Kala Bhavan, S. P Road, Secunderabad, Telangana, India- 500003
3 Head , Department of Clinical Audit, Yashoda Hospitals, Behind Hari - Hara Kala Bhavan, S. P Road, Secunderabad, Telangana, India - 500003

Case Report
 
World Journal of Biology Pharmacy and Health Sciences, 2024, 19(02), 551–555.
Article DOI: 10.30574/wjbphs.2024.19.2.0544
DOI url: https://doi.org/10.30574/wjbphs.2024.19.2.0544

Received on 12 July 2024; revised on 25 August 2024; accepted on 28 August 2024

Background: Kounis Syndrome is a hypersensitive coronary artery disease caused by the body being exposed to allergens that can be triggered by various medications and environmental factors. The body's defense mechanism launches a surge of chemicals during an anaphylactic reaction that could cause a state of shock, drop in blood pressure and constriction of the breathing passage, which makes breathing difficult.
Case presentation: A 55-year-old woman presented in our department with edema and a growth over her right buccal mucosa. A punch biopsy performed was indicative of squamous cell carcinoma. Considering Chronic Kidney Disease (CKD), consultation with a nephrologist was scheduled and proceeded with the advised recommendations. Following the first injection dose of Cefoperazone and Sulbactum, within 5 minutes, the patient reported chest discomfort and difficulty in breathing. CPR was given according to ACLS protocol. Adrenaline injection was administered and was connected to defibrillator shock.
Conclusion: It is imperative for healthcare providers and pharmacists to recognize that, cephalosporins may result in fatal disorders such as Kounis Syndrome (KS) in order to appropriately prescribe the treatment and take preventative measures.

Kounis syndrome; Cefoperazone; Sulbactum; Cephalospronins; Anaphylaxis

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2024-0544.pdf

Preview Article PDF

C.N. Harshitha, Bharat A. Vaswani and Yerravalli Narasimha Rao. A case report on cefoperazone induced cardiogenic shock - kounis syndrome. World Journal of Biology Pharmacy and Health Sciences, 2024, 19(02), 551–555. Article DOI: https://doi.org/10.30574/wjbphs.2024.19.2.0544

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution